An internally validated new clinical and inflammation-based prognostic score for patients with advanced hepatocellular carcinoma treated with sorafenib.

Roberto Diaz-BeveridgeG BruixolaD LorenteJ CaballeroE RodrigoÁ SeguraD AkhoundovaA GiménezJ Aparicio

Published in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2017)

PS and C-P score were the main prognostic factors for OS, followed by early-onset diarrhoea and bNLR. We identified four risk groups for OS depending on these parameters. This prognostic model could be useful for patient stratification, but an external validation is needed.

Keyphrases

early onset
prognostic factors
late onset
oxidative stress
case report
irritable bowel syndrome